Newly synthesized cellular proteins can be tagged with a variety of metabolic labels that distinguish them from preexisting proteins and allow them to be identified and tracked. Many such labels are incorporated into proteins via the endogenous cellular machinery and can be used in numerous cell types and organisms. Though broad applicability has advantages, we aimed to develop a strategy to restrict protein labeling to specified mammalian cells that express a transgene. Here we report that heterologous expression of a mutant methionyl-tRNA synthetase from Escherichia coli permits incorporation of azidonorleucine (Anl) into proteins made in mammalian (HEK293) cells. Anl is incorporated site-selectively at N-terminal positions (in competition with initiator methionines) and is not found at internal sites. Site selectivity is enabled by the fact that the bacterial synthetase aminoacylates mammalian initiator tRNA, but not elongator tRNA. N-terminally labeled proteins can be selectively conjugated to a variety of useful probes; here we demonstrate use of this system in enrichment and visualization of proteins made during various stages of the cell cycle. N-terminal incorporation of Anl may also be used to engineer modified proteins for therapeutic and other applications. T o ensure proper function, cells must make the right proteins at the right times and in the correct amounts. The protein synthesis program of the cell depends on many factors, including environment, developmental stage, and cell type. As cells encounter stresses or other stimuli, protein synthesis is adjusted, allowing cells to accommodate changing conditions and respond to external signals. Because changes in protein synthesis can occur rapidly (1), time-resolved methods are needed to track newly synthesized proteins on timescales of a few minutes. Such measurements are challenging because new proteins are often far outnumbered by their older counterparts (e.g., the amount of protein produced in 1 h by a growing HeLa cell accounts for less than 1% of the total protein content of the cell) (2) .
Newly synthesized proteins can be tagged with metabolic labels that allow them to be identified, quantified, or visualized. Current strategies use isotopic amino acids (which can be tracked by mass spectrometry) (3) or bioorthogonal labels that can be selectively conjugated to dyes and affinity probes (4) . Labels such as "heavy" lysine, azidohomoalanine (Aha) (5), or O-propargyl-puromycin (OP-puro) (6) can be introduced to cells in a pulse during which actively translated proteins are tagged. Incorporation of these labels requires only the endogenous cellular machinery, making them broadly applicable across cell types and organisms. However, global incorporation of the label can be disadvantageous. For instance, elucidating cell-specific programs of protein synthesis in complex cellular systems (e.g., cocultures, tissues, and multicellular organisms) is challenging because proteins derived from different cell types are chemically indistinguishable. Though heavy lysine, Aha, and OP-puro are powerful tools for labeling proteins in time-resolved fashion, they lack the cell selectivity needed to understand cell-to-cell variation in heterogeneous systems (7) . Thus, cell-selective tools for the study of protein synthesis are also required.
In 2009, we reported a strategy for cell-selective metabolic labeling of proteins in complex cellular mixtures (8) . Expression of the L13N/Y260L/H301L mutant form of the Escherichia coli methionyl-tRNA synthetase (referred to as NLL-EcMetRS) enables cells to use the methionine (Met) surrogate azidonorleucine (Anl; Fig. 1A ; SI Appendix, Fig. S1 ) in protein synthesis (8, 9) . Proteins made in cells that express the NLL-EcMetRS can be labeled with Anl during a pulse in which the noncanonical amino acid competes with Met in the decoding of AUG codons. Anl-labeled proteins can be selectively conjugated to affinity probes (for enrichment) (10) or fluorescent dyes (for visualization) (11, 12) . Expression of the mutant synthetase in a subset of cells in a cellular mixture restricts labeling to that subset. Proteins synthesized in cells that do not express the synthetase are not labeled. In multicellular environments, this approach simplifies the protein population and permits identification of the cellular origins of labeled proteins (8, 13) .
Recently we sought to extend cell-selective labeling to proteins made in mammalian systems. Previous work had shown that wild-type EcMetRS catalyzes aminoacylation of mammalian tRNA (14) , and that it is functional when expressed in COS-1 cells (15) . Thus, we pursued heterologous expression of NLLEcMetRS as an initial strategy. Because Anl is not used by the endogenous mammalian translational machinery (8), we anticipated that labeling would be limited to cells that express the mutant bacterial MetRS.
Here we demonstrate that heterologous expression of NLLEcMetRS enables incorporation of Anl into proteins expressed in HEK293 cells. Furthermore, we show that Anl is incorporated site selectively at N-terminal positions and is not introduced at internal sites. Site selectivity is a consequence of the fact that NLL-EcMetRS catalyzes aminoacylation only of the mammalian initiator tRNA (tRNA i Met ), as does the wild-type bacterial MetRS (14) (15) (16) (17) (18) (19) . Elongator Met tRNAs (tRNA Met ) are not recognized by the NLL-EcMetRS and are charged only with Met. The use of tRNA i Met only in translational initiation (16, (18) (19) (20) (21) directs Anl to N-terminal positions and prohibits its insertion at internal sites. Here we describe the use of this system in labeling, detection, and visualization of newly synthesized proteins in mammalian cells, and demonstrate its utility by examining cell cycle-dependent changes in translation.
Results

NLL-EcMetRS Selectively Aminoacylates Mammalian Initiator tRNA.
We first determined whether the NLL-EcMetRS retained selectivity for eukaryotic tRNA i Met . Synthetic tRNA i Met and tRNA Met sequences were prepared by the run-off transcript method (22) and treated in vitro with purified NLL-EcMetRS. tRNA i Met and tRNA Met from Caenorhabditis elegans were compared with the equivalent bacterial sequences. Formation of AnltRNAs was monitored by strain-promoted conjugation of the Anl side chain to difluorinated cyclooctyne (DIFO)-functionalized Alexa Fluor 488 (DIFO-Alexa Fluor 488) (23) . Fluorescently labeled tRNAs were separated on 2% agarose gels and detected by in-gel fluorescence scanning. Though we observed aminoacylation of eukaryotic tRNA i Met , we found no evidence of charging of eukaryotic tRNA Met by the bacterial synthetase (SI Appendix, Fig. S2 ).
Expression of NLL-EcMetRS Enables Incorporation of Anl into Proteins
Made in Mammalian Cells. A stable HEK293-derived cell line constitutively expressing NLL-EcMetRS (referred to as HEK293-8D3) was generated by transfection. We confirmed that the bacterial synthetase was expressed as a soluble and intact protein in the HEK293-8D3 cytoplasm (SI Appendix, Fig. S3 ). To determine whether HEK293-8D3 cells could incorporate Anl into proteins, cells were treated with 1 mM Anl for 4 h. Because the specificity constant (k cat /K m ) of the NLL-EcMetRS is higher for Anl than for Met (9), we anticipated that incorporation of Anl would occur even in the presence of high concentrations of Met. Thus, cells were not depleted of Met, and Anl was added to standard growth medium (Materials and Methods). After 4 h, Anllabeled proteins were detected by Cu (I)-catalyzed azide-alkyne ligation (24) to Alexa Fluor 488-alkyne in fixed (permeabilized) cells. Imaging of cells by fluorescence microscopy revealed prominent labeling of proteins in HEK293-8D3 cells (Fig. 1D) , whereas nontransfected cells exhibited only background levels of fluorescence. HEK293-8D3 cells treated with Anl and the protein synthesis inhibitor anisomycin were only dimly fluorescent, indicating that fluorescence arises predominantly from proteins made during the Anl pulse.
We tested various pulse times and Anl concentrations, and estimated the relative levels of Anl tagging after treatment of cell lysates with a dibenzoazacyclooctyne (DIBAC)-functionalized tetramethylrhodamine dye (25) (DIBAC-TAMRA; SI Appendix, 
Enrichment of Labeled Proteins and Analysis by Tandem Mass
Spectrometry. To determine whether Anl was incorporated into cellular proteins only at N-terminal positions, we subjected labeled proteins to analysis by mass spectrometry. First, Anl-tagged proteins were labeled with a DIBAC-functionalized biotin reagent (DIBAC-biotin; SI Appendix, Fig. S1 ) and enriched by binding to immobilized streptavidin (Materials and Methods). The specificity of the enrichment step was examined by comparing lysates from transfected and nontransfected cells (SI Appendix, Fig. S6A ). Though numerous proteins were enriched from the lysate of transfected cells, proteins were not detected in the elution fraction of the mock enrichment experiment (i.e., from nontransfected cells treated with Anl). To estimate the extent of enrichment, purified GFP containing a single Anl residue was mixed with unlabeled lysate and recovered by the same procedure. By comparison of Coomassie-stained proteins in the initial mixture to those released from streptavidin, we estimate that GFP was enriched by at least 500-fold (SI Appendix, Fig. S6B ).
Proteins enriched from cell lysates were digested with trypsin, and the tryptic peptides were analyzed by tandem mass spectrometry. The collected spectra were used to direct a peptide identification search in which the masses of Anl and DIBACbiotin-modified Anl were included as variable modifications (SI Appendix, Fig. S7) . In an initial analysis we identified 1,690 peptides (Table 1 and Dataset S1). Most notably, the N-terminal tryptic fragment of polypyrimidine tract binding protein-1 (PTBP-1; a housekeeping protein) was detected with an N α -acetylated, DIBAC-biotin-modified Anl in place of Met (SI Appendix, Fig.  S8 ). The mass of the parent ion matched the expected mass of the substituted peptide, and the modification was directly observed in both the b-and y-ion spectra upon fragmentation. Including fragments identified from internal regions of the protein, PTBP-1 was detected with 43% sequence coverage and 15 unique peptides (three of which contained one or more internal Met residues).
In addition to the PTBP N-terminal peptide, 15 N-terminal peptides that did not contain Anl were also identified (Table 2 and Dataset S1). Eight peptides contained Met at the initiator position; the other seven were derived from proteins from which the initiator amino acid had been removed. Though it is possible that such peptides could have been derived from proteins tagged with Anl at internal positions, we suspected that they were fragments of contaminating proteins present in the elution fraction at low concentrations. Several of these peptides were derived from highly abundant proteins (such as the 70-kDa heat shock protein and γ-actin), which may have not been removed completely during enrichment. The remaining peptides were derived from proteins that were probably enriched unintentionally, such as endogenously biotinylated proteins or proteins covalently attached to Anl-tagged proteins (such as ubiquitin). To eliminate the ambiguity associated with contaminating proteins, we analyzed an enriched proteome collected from cells labeled simultaneously with Anl and [ 13 C 6 , 15 N 2 ]lysine (heavy lysine). When we limited our analysis to peptides that contained the isotopic label, only a single N-terminal peptide lacking Anl was identified (Dataset S1). The N terminus of cofilin-1 was detected without Anl, but with the isotopic label, indicating that it was synthesized during the Anl pulse. Cofilin-1 is known to form intermolecular disulfide bonds (27) , so it may have been carried through the enrichment step while bound to an Anl-tagged partner. None of the other unmodified N termini observed in our initial analysis were detected in the heavy lysine experiment.
To facilitate detection of additional sites of Anl incorporation, we used a cleavable enrichment probe in which a disulfide bond is positioned between the DIBAC and biotin moieties (DIBAC-S-S-biotin; SI Appendix, Fig. S1 ). The selectivity of DIBAC-S-S-biotin was similar to that of DIBAC-biotin with respect to labeling of cysteine-free proteins (SI Appendix , Fig. S9) ; for proteomic analyses, protein samples were reduced and alkylated before treatment with DIBAC-S-S-biotin. Following enrichment, reduction of the disulfide bond releases a fragment of the probe from modified proteins. The fragment that remains appended to the site of modification is more than 200 mass units smaller than that obtained upon treatment with DIBAC-biotin, and is more readily detected by MS analysis. We enriched proteins from labeled cell lysates by using the cleavable probe and analyzed them as before, with the fragment derived from reduced and alkylated DIBAC-S-S-biotin as an additional variable substitution (SI Appendix, Fig. S7 ). Eleven additional Anl modifications were identified by using the cleavable probe, each of which corresponded to a unique N-terminal peptide (Table 1 ; SIAppendix, Figs. S8B and S10; Dataset S1).
In
Met can be used by the cell to initiate translation. Though we identified 1,671 peptides containing one or more Met residues and sampled 2,165 Met positions (2,151 of which were internal), we did not find evidence of Anl incorporation at internal positions (Table 1) .
N-Terminal Anl Is Cleaved by Methionyl Aminopeptidase at an Attenuated Rate. N-terminal Met residues are subject to excision from proteins by methionyl aminopeptidases (MetAPs) (28) . Noncanonical amino acids at N-terminal sites can also be subject to N-terminal excision, although the rate of cleavage is typically reduced (29, 30) . To investigate removal of Anl, we measured the activity of recombinant human MetAP-2 (cytoplasmic form) using Anl-7-amino-4-methylcoumarin (Anl-AMC; SI Appendix, Fig. S11A ) and Met-7-amino-4-methylcoumarin (Met-AMC; SI Appendix, Fig. S11A ) as substrates in a fluorometric assay. Though the enzyme cleaved both Anl-AMC and Met-AMC, kinetic analysis revealed that cleavage of Anl-AMC was approximately threefold slower (SI Appendix, Fig. S11B ). We suspect that the rate of Anl excision inside cells may be even further attenuated, because treatment of cells with fumagillin (a MetAP-2 inhibitor) led to only a slight increase in the amount of Anl-labeled protein detected in cell lysates (SI Appendix, Fig. S11C ). Several known MetAP substrates were detected with Anl residues at N-terminal positions (SI Appendix, Table S1 ).
N-Terminal Anl Is Recognized by N
α -Acetyltransferases. Proteins are subject to modification by N α -acetyltransferases (NATs), which catalyze the addition of acetyl groups to the N termini of substrate proteins (28) . N α -acetylation occurs primarily cotranslationally as nascent polypeptides emerge from the ribosome. Substrate selection is governed by N-terminal sequence determinants (31); it is estimated that more than 80% of human proteins are NAT substrates (32) . Of the 12 peptides identified with N-terminal modifications, seven were derived from known NAT substrates; all seven were detected in N α -acetyl-Anl form (SI Appendix, Table S2 ). The remaining five fragments were detected with unmodified terminal amines and were derived from proteins that do not normally contain N α -acetyl-Met.
Distribution of Newly Synthesized Proteins Is Cell-Cycle Dependent.
Fluorescence imaging of dye-labeled HEK293-8D3 cells revealed striking cell-to-cell variation in the localization of newly synthesized proteins. Though many cells exhibited nearly uniform spatial distributions of labeled proteins, a portion of the cell population (approximately one-third of all cells) displayed prominent intensities that colocalized with the nuclear stain Hoechst 33342 ( Fig. 2A) , suggesting that in these cells, much of the newly synthesized protein was translocated to the nucleus. To identify these proteins, we analyzed subcellular protein fractions by treatment with DIBAC-TAMRA, electrophoretic separation, and in-gel fluorescence scanning. In gels prepared from the nuclear fraction of Anl-treated HEK293-8D3 cells, we observed TAMRA-labeled proteins that migrated in a pattern characteristic of the core histone proteins (Fig. 2B) . Histone labeling is consistent with the imaging results discussed previously; histones are abundant nuclear proteins synthesized predominantly during S phase of the cell cycle (33). Because we labeled growing, asynchronous cells, a fraction of the population was undoubtedly in S phase. Thus, the prominent nuclear intensities we saw in a fraction of cells were likely the result of labeled histones synthesized and translocated to the nucleus by cells undergoing DNA replication. To verify that the observed intensities did in fact represent newly synthesized histones, we treated HEK293-8D3 cells with Anl in the presence of hydroxyurea (HU), which slows histone synthesis by reducing the levels of histone messenger RNAs in the cell (34) . Imaging confirmed that the localized intensities did indeed represent new histones, because these intensities were not observed in HU-treated cells (Fig. 3A) . We also analyzed total protein and histone extracts from Anl-treated cells by DIBAC-TAMRA labeling and in-gel fluorescence scanning. Though the majority of the labeled proteins appeared to be unchanged, HU treatment led to significantly diminished TAMRA intensity at bands corresponding to the core histone proteins (H3, H2B, H2B, H4) and the adaptor histone (H1; Fig. 3 B and C) . The decrease in TAMRA intensity (83% decrease; SI Appendix, Fig. S12 ) agreed with previous measurements of the effect of HU on histone synthesis determined by using [ 3 H]lysine (80-85% decrease) (35) . In cells that were treated with HU before the pulse and released from the agent shortly before adding Anl, an intermediate level of histone synthesis was observed. Notably, none of the effects of HU treatment on histone synthesis could be detected in conventional Coomassie-stained gels (Fig. 3 B and C) . HU acts by quenching the tyrosyl radical of ribonucleotide reductase, thus limiting the pool of nucleotides available for DNA synthesis (36) . Because histone and DNA synthesis are tightly coupled, HU also inhibits histone translation. In addition, HU elicits the genotoxic stress response and leads to stabilization of the p53 tumor suppressor (37) . p53 is a transcription factor that is continually synthesized, but normally targeted for rapid degradation; the transcription factor is activated by phosphorylation, which inhibits its ubiquitination and, in turn, its degradation. As a result, newly synthesized p53 accumulates and enters the nucleus, where it facilitates transcription of target genes that mediate cell-cycle arrest.
In analysis of Anl-labeled proteins, we detected a band with an approximate mass of 53 kDa that was present in HU-treated samples and absent from untreated and HU-released samples (Fig. 4A ). Western analysis with anti-p53 antibody confirmed stabilization of p53 in HU-treated cells; the position of the antibody-labeled band matched that of the 53-kDa TAMRAlabeled band induced by HU. Both the HU-mediated decrease in histone translation and stabilization of p53 were observed in direct analysis of enriched proteins (Fig. 4B) .
Discussion
Noncanonical amino acids have been used to measure the kinetics of protein and nucleosome turnover (38, 39) , visualize local protein synthesis in neuronal subcompartments (40, 41) , and identify the products of stimulus-induced protein synthesis in axons and dendrites (42, 43) . Here we introduce an additional level of control in the metabolic labeling of proteins made in mammalian cells, by using a noncanonical amino acid that requires a mutant aminoacyltRNA synthetase for activation. We believe that this system will enable cell-selective interrogation of protein synthesis in cocultures of mammalian cells or in virally transfected tissues. Use of Aha to examine protein synthesis in zebrafish has recently been described (44) ; extension of the strategy introduced here should permit cellselective analysis in vivo and provide a valuable complement to existing methods for cell-selective isolation of mRNAs (45) (46) (47) . Use of promoters to limit expression of mutant synthetases to specific cell states (such as specific developmental stages) (48) may allow further refinement of labeling specificity. It is important to note that NLL-EcMetRS may not prove to be the synthetase of choice for such experiments; our preliminary efforts to prepare transgenic C. elegans strains that express NLL-EcMetRS under control of cell-selective promoters have thus far been unsuccessful.
Expression of NLL-EcMetRS enables incorporation of Anl specifically at the N termini of proteins made in mammalian cells. The bacterial synthetase accepts the mammalian initiator tRNA, but none of the mammalian elongator tRNAs, as a substrate. Discrimination against mammalian elongator tRNAs is an intrinsic property of the bacterial MetRS; the enzyme recognizes Met tRNAs with seven-member anticodon loops (such as bacterial Met tRNAs and mammalian tRNA i Met ) but not those with nine-member anticodon loops (such as the mammalian cytoplasmic elongator tRNA Met ) (17) . Selective charging in this manner prohibits Anl incorporation at internal positions. We reasoned that a confident determination of selective N-terminal incorporation required (i) direct evidence of translational initiation with Anl and (ii) a reliable inference of the absence of Anl at internal positions. We identified 12 peptides that provided direct evidence of Anl at N-terminal positions. These peptides provided confirmation that Anl was indeed charged to tRNA i Met and that Anl-tRNA i Met could be used to initiate protein synthesis. Evidence of Anl incorporation at internal sites was not observed despite sampling a total of 2,143 Met positions in 1,671 peptides. This result is especially significant considering that N-terminal peptides are substantially outnumbered by internal Met-containing peptides in any digested proteome. For instance, trypsin digestion of the E. coli and human proteomes generates on average 28 and 45 peptides per protein, respectively (49) . The E. coli genome encodes 8.2-fold more internal Mets than initiator Mets, and the human genome encodes 9.2-fold more
[average values calculated from the codon distribution of the protein coding genes of E. coli and Homo sapiens genomes from National Center for Biotechnology Information (NCBI) GenBank Release 160]. Thus, even if Anl were incorporated 10× more slowly at internal sites than at N-terminal sites, one would expect to detect comparable numbers of N-terminal and internal modifications. Consistent with this argument are the results of Nessen et al. (50) , who reported an analysis of peptides isolated from proteome-wide labeling in E. coli and found 10-fold more Aha modifications at internal sites than at N termini.
We found that the rate of MetAP-catalyzed excision of Nterminal Anl residues was attenuated in comparison with that observed for N-terminal Met. However, because Anl is incorporated selectively at N-terminal positions, proteins that are subject to cleavage of N-terminal signal sequences would not retain their Anl labels. In an unbiased analysis of N-terminal peptides collected from Jurkat cells, 32% of the identified N termini indicated a non-MetAP proteolytic cleavage site or an alternative translational initiation site (51) . These "neo" N termini may have been generated following cleavage by signal peptidases (52), mitochondrial processing peptidase (52) , or other intracellular proteases. Development of mutant mammalian synthetases that would permit incorporation of labels at internal positions would complement the labeling method introduced here, by allowing enrichment and identification of proteins that lack N-terminal Met residues.
Finally, we anticipate that the approach introduced here will be useful in preparing proteins containing site-specific modifications for biotechnological applications. Selective aminoacylation by EcMetRS has been previously used to produce proteins containing N-terminal biotinylated or fluorescent Met derivatives in cell-free systems (53) (54) (55) . Adaptation of the methods introduced here to suspension culture of mammalian cells would complement existing strategies (56-58) for preparation of site-specific protein conjugates.
Materials and Methods
Full details regarding experimental procedures and the compounds used in this study can be found in SI Appendix, SI Materials and Methods.
Anl Labeling Procedure. HEK293 cells were grown in Dulbecco's Modified Eagle Medium containing 10% (vol/vol) FBS, penicillin, and streptomycin, and 50 μg·mL −1 Geneticin at 37°C, with 5% CO 2 using standard procedures.
The culture medium was exchanged with fresh medium either several Coomassie staining and streptavidin detection of proteins enriched from untreated and HU-treated cell lysates using DIBAC-biotin. Decreased histone translation (red arrowheads) and p53 stabilization seen during analysis of cell lysates were also apparent following enrichment (blue arrowhead).
hours or the night before each experiment. Cells at 70-80% confluence were labeled by addition of Anl to the culture medium at the indicated concentrations and incubated for the indicated times at 37°C under 5% CO 2 . Labeling was terminated by aspiration of the culture medium, and cells were washed with PBS and collected by trypsinization and centrifugation. Pelleted cells were washed with PBS to remove trypsin and stored at −20°C until further processing.
Protein Modification and Detection with DIBAC-Functionalized Probes. DIBAC probe stocks (5-20 mM) were prepared in DMSO, and conjugation reactions were initiated by dilution of probe into solutions of alkylated proteins to a final concentration of 20 μM. Reactions with DIBAC-TAMRA were incubated at room temperature for 20 min with gentle mixing and protection from light. Reactions with DIBAC-biotin and DIBAC-S-S-biotin were mixed gently at room temperature for 1 h. Reactions were quenched by addition of a fivefold excess (with respect to probe) of free Anl and immediately mixed by vortexing.
